RCT | 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy.
4 Aug, 2022 | 14:33h | UTCRelated:
WHO Recommends Dolutegravir as Preferred HIV Treatment Option in All Populations
RCT: Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir to treat HIV.